iPAM Cell Differentiation via Wnt Activation and BMP Inhibition

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for differentiating embryonic stem (ES) and induced pluripotent stem (iPS) cells into paraxial mesoderm derivatives, such as skeletal muscle and bone, are inefficient and often require genetic modification or limited spontaneous differentiation, posing challenges for regenerative medicine applications.

Innovation Solution

A method involving the culture of pluripotent cells in a medium with an activator of the Wnt signaling pathway, specifically members of the R-spondin family or GSK-3β inhibitors, and an inhibitor of the Bone Morphogenetic Protein (BMP) signaling pathway, like R-spondin and Noggin, to efficiently produce induced Paraxial Mesoderm progenitor (iPAM) cells without genetic modification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional differentiation methods are used for ES and iPS cells into paraxial mesoderm derivatives, then some differentiation can be achieved, but the efficiency is low and genetic modification is required

Engineering Contradiction:

Improvedifferentiation efficiencyVSAvoidgenetic modification requirement

Core Design Contradiction:

ProductivityVSDevice complexity

Solution Approach 1:

The patent applies parameter changes by modifying culture conditions - specifically using small molecule inhibitors (SB431542 for BMP signaling, LDN-193189 for TGF-beta signaling) and activators (R-spondin for Wnt signaling) to redirect cell differentiation. This chemical parameter modification achieves high-efficiency paraxial mesoderm differentiation without genetic modification, resolving the contradiction between productivity improvement and device complexity reduction

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent replaces the mechanical/genetic approach (genetic modification) with a chemical/biochemical approach (small molecule inhibitors and activators in culture medium). This substitution eliminates the need for complex genetic manipulation while achieving superior differentiation efficiency, directly addressing the technical contradiction

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

2Quantity of substance

If spontaneous differentiation is used, then some paraxial mesoderm cells can be obtained, but the yield is limited and efficiency is low

Engineering Contradiction:

Improveyield of iPAM cellsVSAvoiddifferentiation efficiency

Core Design Contradiction:

Quantity of substanceVSProductivity

Solution Approach 1:

The patent applies preliminary action by pre-treating pluripotent cells with specific culture conditions containing signaling pathway modulators before differentiation. The cells are prepared with inhibited BMP and TGF-beta pathways and activated Wnt pathway in advance, which primes them for efficient paraxial mesoderm differentiation and increases both yield and efficiency of iPAM cell production

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent introduces intermediary substances - small molecule inhibitors (SB431542, LDN-193189) and activators (R-spondin) - that mediate the differentiation process. These intermediaries control signaling pathways to guide pluripotent cells toward paraxial mesoderm fate, significantly increasing both the quantity and efficiency of iPAM cell generation compared to spontaneous differentiation

Inventive Principle:

Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the efficient production of iPAM cells that exhibit characteristics of endogenous Paraxial mesoderm progenitors, capable of differentiating into skeletal, dermal, and endothelial lineages, offering a promising solution for regenerative medicine by providing a scalable and safe source of cells for muscle, bone, and cartilage regeneration.

Implementation Method 1

R-spondins (Rspo1 to 4 genes) are secreted molecules containing a thrombospondin domain, that can activate canonical Wnt signaling and Beta-Catenin, via the Fzd/LRP/Lgr4/Lgr5 co-receptors complex

Methodology Applied

Scientific EffectWnt signaling pathway activation:

Implementation Method 2

Bone Morphogenetic Proteins (BMPs) are secreted molecules of the TGFbeta superfamily that can dimerize and activate BMP signaling and bind to a receptor complex constituted of BMP receptor type I and type II

Methodology Applied

Scientific EffectBMP signaling pathway inhibition:

Data Source

PatentEP2756075B1Method for preparing induced paraxial mesoderm progenitor (IPAM) cells and their use

Publication Date: 2019.10.02 INST NAT DE LA SANTE & DE LA RECHERCHE MEDICALE (INSERM)

Figure 1A~1B
Figure 2A~2B
Figure 3A~3B

AI summary

The present invention relates to an ex vivo method for preparing induced paraxial mesoderm progenitor (iPAM) cells, said method comprising the step of culturing pluripotent cells in an appropriate culture medium comprising an effective amount of an activator of the Wnt signaling pathway and an effective amount of an inhibitor of the Bone Morphogenetic Protein (BMP) signaling pathway.